ESC 365 - Effect of Sildenafil on Clinical Outcomes in Patients with Corrected Valvular Heart Disease and Residual Pulmonary Hypertension.

ESC Premium Access

Effect of Sildenafil on Clinical Outcomes in Patients with Corrected Valvular Heart Disease and Residual Pulmonary Hypertension.

Session: Hot Line: Late-Breaking Clinical Trials 3

Topic: Valvular heart disease, other

Speaker: Doctor J. Bermejo Thomas (Madrid, ES)

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Doctor Javier Bermejo Thomas

University Hospital Gregorio Maranon, Madrid (Spain)

6 presentations

0 follower

14 more presentations in this session

Naturally randomized 'REVEAL' trial

Speaker: Professor B. Ference (Cambridge, GB)

Discussant review: A Naturally Randomized Trial Comparing the Effect of Genetic Variants that Mimic CETP Inhibitors and Statins on the Risk of Cardiovascular Disease

Speaker: Professor B. Nordestgaard (Copenhagen, DK)

Panel discussion.

Discussant review: Effect of Sildenafil on Clinical Outcomes in Patients with Corrected Valvular Heart Disease and Residual Pulmonary Hypertension.

Speaker: Professor I. Lang (Vienna, AT)

Panel discussion.

Access the full session

Hot Line: Late-Breaking Clinical Trials 3

Speakers: Doctor J. Bermejo Thomas, Professor B. Ference, Professor B. Nordestgaard, Professor I. Lang

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources